These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28622413)

  • 21. Combining biologics with methotrexate in psoriasis: a systematic review.
    van Bezooijen JS; Prens EP; Pradeepti MS; Atiqi R; Schreurs MWJ; Koch BCP; van Gelder T; van Doorn MBA
    Br J Dermatol; 2015 Jun; 172(6):1676-1680. PubMed ID: 25470815
    [No Abstract]   [Full Text] [Related]  

  • 22. A prospective observational study of pigmented naevi changes in psoriasis patients on biologic therapy.
    Choi SD; D'Souza MI; Menzies SW; Weninger W
    Australas J Dermatol; 2019 Feb; 60(1):e14-e19. PubMed ID: 29797312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologics for psoriasis: more drugs, new patient categories, but fresh challenges for clinical dermatologists.
    Pink AE; Smith CH
    Br J Dermatol; 2017 Jul; 177(1):7-8. PubMed ID: 28731243
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of biologics and other systemic agents in the treatment of pediatric psoriasis.
    Wright NA; Piggott CD; Eichenfield LF
    Semin Cutan Med Surg; 2010 Mar; 29(1):20-7. PubMed ID: 20430304
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
    Reich K; Mrowietz U; Radtke MA; Thaci D; Rustenbach SJ; Spehr C; Augustin M
    Arch Dermatol Res; 2015 Dec; 307(10):875-83. PubMed ID: 26358263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
    Busard CI; Cohen AD; Wolf P; Gkalpakiotis S; Cazzaniga S; Stern RS; Hutten BA; Feldhamer I; Quehenberger F; Lichem R; Kojanova M; Adenubiova E; Addis A; Naldi L; Spuls PI
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):245-253. PubMed ID: 28898541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: results of a multicentre randomized controlled trial.
    Prinsen CA; Spuls PI; Lindeboom R; Sprangers MA; de Rie MA; de Korte J
    Br J Dermatol; 2015 Oct; 173(4):1091-4. PubMed ID: 25975387
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
    Alwawi EA; Krulig E; Gordon KB
    Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-tuberculous mycobacterial infections in psoriasis patients treated with biologics.
    Choi YM; Adelzadeh L; Wu JJ
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e99-e101. PubMed ID: 26388307
    [No Abstract]   [Full Text] [Related]  

  • 30. Advanced Therapy Treatment for Psoriasis: A Single-Site Retrospective Study of Prescribing Outcomes.
    Kim C; Joerg L; Levitt J
    Skinmed; 2017; 15(6):493-495. PubMed ID: 29282198
    [No Abstract]   [Full Text] [Related]  

  • 31. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
    Kojanova M; Fialova J; Cetkovska P; Gkalpakiotis S; Jircikova J; Dolezal T; Arenberger P;
    Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of systemic treatments for psoriasis in elderly patients.
    Piaserico S; Conti A; Lo Console F; De Simone C; Prestinari F; Mazzotta A; Gualdi G; Guarneri C; Borsari S; Cassano N
    Acta Derm Venereol; 2014 May; 94(3):293-7. PubMed ID: 24158307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic therapy with or without topical treatment in psoriasis: what does the current evidence say?
    Jensen JD; Delcambre MR; Nguyen G; Sami N
    Am J Clin Dermatol; 2014 Oct; 15(5):379-85. PubMed ID: 25027461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis.
    Blauvelt A; Reich K; Warren RB; Szepietowski JC; Sigurgeirsson B; Tyring SK; Messina I; Bhosekar V; Oliver J; Papavassilis C; Frueh J; Langley RGB
    Br J Dermatol; 2017 Sep; 177(3):879-881. PubMed ID: 28498514
    [No Abstract]   [Full Text] [Related]  

  • 35. Practical experience of biologics for treatment of very severe psoriasis: a retrospective case cohort study of patients with a baseline Psoriasis Area and Severity Index greater than 20.
    Ponnambath N; Kalavala M; Anstey AV; Piguet V; Ingram JR
    Clin Exp Dermatol; 2016 Jan; 41(1):95-6. PubMed ID: 25817265
    [No Abstract]   [Full Text] [Related]  

  • 36. Inequalities in access to biological treatments for psoriasis: results from the Italian Psocare registry.
    Naldi L; Cazzaniga S; Di Mercurio M; Grossi E; Addis A;
    Br J Dermatol; 2017 May; 176(5):1331-1338. PubMed ID: 27973689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
    Ross C; Marshman G; Grillo M; Stanford T
    Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switching biologics in severe pediatric psoriasis: a retrospective analysis.
    Ramos Pinheiro R; Diamantino F; Cabete J; Brasileiro A; Baptista J; Lopes MJP
    Int J Dermatol; 2017 Dec; 56(12):1461-1464. PubMed ID: 28960270
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacies of biological therapies at week 12 in patients with plaque psoriasis in real-world academic clinical practice: a Canadian multicentre retrospective study.
    Shahbaz A; Qiang J; Marinas JEC; Kim WB; Greaves S; Yeung J
    Br J Dermatol; 2017 Jul; 177(1):297-298. PubMed ID: 27639251
    [No Abstract]   [Full Text] [Related]  

  • 40. Resource use in patients with psoriasis after the introduction of biologics in Sweden.
    Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M
    Acta Derm Venereol; 2015 Feb; 95(2):156-61. PubMed ID: 24819980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.